RNXT

RenovoRxD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

Current thesis

Composite grade D from latest DB weights. Momentum 40.1 / Value 41.1

Posture

Defensive

Lead driver

Value

What changed

Value remains the lead driver in the composite, 7D delta -0.1.

What can break

Mixed signals. Wait for cleaner trend confirmation.

Momentum

Value

Sentiment

N/A

Setup hits (3d)

— · Net —

AI TargetsBase - · Bull - · Bear -

Data freshness

Prices

As of 2026-07-18

Fundamentals

As of 2026-07-17 • Vendor: Data Vendor v1

Scores

As of 2026-07-18 • Model: HYBRID_IC_RP

AI Memo

Unavailable: No memo yet

Investment thesis

As of 2026-07-18

Supporting evidence

What

Grade D · Defensive

Confidence Medium · Net —

Target $7.00

Why

Momentum40 · Δ7d -

Value41 · Δ7d -0.1

SentimentN/A · Δ7d -

So what

Weak posture. Prioritize risk control and patience.

Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits

Lead driver: Value · See fundamentals

Momentum

40% active weight

Current posture

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Value

60% active weight

Current posture

7d trendFlat

Δ7d

-0.1

Δ21d

0.0

Sentiment

N/A

Coverage pending

No current score

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade D. Momentum 40.1 / Value 41.1

Fundamentals (TTM)

As of 2026-07-17

Market Cap

$38.98M

Beta

1.30

Shares Out

45.05M

P/E (TTM) · Derived

-2.7

P/S (TTM)

37.52

P/FCF (TTM) · Derived

-2.84

Rev YoY

+185.8%

EPS YoY

+20.1%

Gross Margin

+78.7%

Op Margin

-1252.2%

Net Debt

-$6.81M

Current Ratio

7.15

As of 2026-07-18 • Updated nightlySource: Internal modelMethodology